UniProt ID | UBP44_HUMAN | |
---|---|---|
UniProt AC | Q9H0E7 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase 44 | |
Gene Name | USP44 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 712 | |
Subcellular Localization | Nucleus . Peaks in interphase, with relatively low levels maintained throughout mitosis.. | |
Protein Description | Deubiquitinase that plays a key regulatory role in the spindle assembly checkpoint or mitotic checkpoint by preventing premature anaphase onset. Acts by specifically mediating deubiquitination of CDC20, a negative regulator of the anaphase promoting complex/cyclosome (APC/C). Deubiquitination of CDC20 leads to stabilize the MAD2L1-CDC20-APC/C ternary complex (also named mitotic checkpoint complex), thereby preventing premature activation of the APC/C. Promotes association of MAD2L1 with CDC20 and reinforces the spindle assembly checkpoint. Acts as a negative regulator of histone H2B (H2BK120ub1) ubiquitination.. | |
Protein Sequence | MLAMDTCKHVGQLQLAQDHSSLNPQKWHCVDCNTTESIWACLSCSHVACGRYIEEHALKHFQESSHPVALEVNEMYVFCYLCDDYVLNDNTTGDLKLLRRTLSAIKSQNYHCTTRSGRFLRSMGTGDDSYFLHDGAQSLLQSEDQLYTALWHRRRILMGKIFRTWFEQSPIGRKKQEEPFQEKIVVKREVKKRRQELEYQVKAELESMPPRKSLRLQGLAQSTIIEIVSVQVPAQTPASPAKDKVLSTSENEISQKVSDSSVKRRPIVTPGVTGLRNLGNTCYMNSVLQVLSHLLIFRQCFLKLDLNQWLAMTASEKTRSCKHPPVTDTVVYQMNECQEKDTGFVCSRQSSLSSGLSGGASKGRKMELIQPKEPTSQYISLCHELHTLFQVMWSGKWALVSPFAMLHSVWRLIPAFRGYAQQDAQEFLCELLDKIQRELETTGTSLPALIPTSQRKLIKQVLNVVNNIFHGQLLSQVTCLACDNKSNTIEPFWDLSLEFPERYQCSGKDIASQPCLVTEMLAKFTETEALEGKIYVCDQCNSKRRRFSSKPVVLTEAQKQLMICHLPQVLRLHLKRFRWSGRNNREKIGVHVGFEEILNMEPYCCRETLKSLRPECFIYDLSAVVMHHGKGFGSGHYTAYCYNSEGGFWVHCNDSKLSMCTMDEVCKAQAYILFYTQRVTENGHSKLLPPELLLGSQHPNEDADTSSNEILS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | Phosphorylation | WHCVDCNTTESIWAC EEEECCCCCCCHHHH | 37.97 | - | |
35 | Phosphorylation | HCVDCNTTESIWACL EEECCCCCCCHHHHH | 17.47 | - | |
45 | Phosphorylation | IWACLSCSHVACGRY HHHHHHCCHHHHHHH | 20.02 | - | |
101 | Phosphorylation | DLKLLRRTLSAIKSQ CHHHHHHHHHHHHHC | 20.73 | 28270605 | |
103 | Phosphorylation | KLLRRTLSAIKSQNY HHHHHHHHHHHHCCC | 27.60 | 28270605 | |
106 | Ubiquitination | RRTLSAIKSQNYHCT HHHHHHHHHCCCEEE | 45.78 | - | |
107 | Phosphorylation | RTLSAIKSQNYHCTT HHHHHHHHCCCEEEC | 19.97 | 28270605 | |
110 | Phosphorylation | SAIKSQNYHCTTRSG HHHHHCCCEEECCCC | 7.22 | 28270605 | |
113 | Phosphorylation | KSQNYHCTTRSGRFL HHCCCEEECCCCCCH | 16.36 | 28270605 | |
114 | Phosphorylation | SQNYHCTTRSGRFLR HCCCEEECCCCCCHH | 28.38 | 28270605 | |
169 | Phosphorylation | FRTWFEQSPIGRKKQ HHHHHHHCCCCCCCC | 15.99 | 22692537 | |
199 | Phosphorylation | KRRQELEYQVKAELE HHHHHHHHHHHHHHH | 31.09 | 25072903 | |
207 | Phosphorylation | QVKAELESMPPRKSL HHHHHHHHCCCCCHH | 49.57 | 25072903 | |
239 | Phosphorylation | VPAQTPASPAKDKVL CCCCCCCCCCCCCCC | 26.96 | 22692537 | |
244 | Ubiquitination | PASPAKDKVLSTSEN CCCCCCCCCCCCCHH | 44.35 | - | |
247 | Phosphorylation | PAKDKVLSTSENEIS CCCCCCCCCCHHHHH | 32.64 | 29449344 | |
248 | Phosphorylation | AKDKVLSTSENEISQ CCCCCCCCCHHHHHH | 35.58 | 29449344 | |
249 | Phosphorylation | KDKVLSTSENEISQK CCCCCCCCHHHHHHH | 34.74 | 29449344 | |
254 | Phosphorylation | STSENEISQKVSDSS CCCHHHHHHHCCCCC | 20.12 | 29449344 | |
256 | Ubiquitination | SENEISQKVSDSSVK CHHHHHHHCCCCCCC | 36.59 | - | |
269 | Phosphorylation | VKRRPIVTPGVTGLR CCCCCCCCCCCCCHH | 18.29 | 22692537 | |
327 | Phosphorylation | SCKHPPVTDTVVYQM CCCCCCCCCEEEEEC | 31.55 | 24719451 | |
342 | Phosphorylation | NECQEKDTGFVCSRQ CCCCCCCCCEEEECC | 43.52 | 24719451 | |
350 | Phosphorylation | GFVCSRQSSLSSGLS CEEEECCHHCCCCCC | 31.94 | 29449344 | |
351 | Phosphorylation | FVCSRQSSLSSGLSG EEEECCHHCCCCCCC | 24.75 | 29449344 | |
353 | Phosphorylation | CSRQSSLSSGLSGGA EECCHHCCCCCCCCC | 25.06 | 29449344 | |
354 | Phosphorylation | SRQSSLSSGLSGGAS ECCHHCCCCCCCCCC | 49.39 | 29449344 | |
357 | Phosphorylation | SSLSSGLSGGASKGR HHCCCCCCCCCCCCC | 38.41 | 29449344 | |
361 | Phosphorylation | SGLSGGASKGRKMEL CCCCCCCCCCCCCEE | 38.63 | 19651622 | |
401 | Phosphorylation | SGKWALVSPFAMLHS CCCCEEECHHHHHHH | 18.36 | 14702039 | |
508 | Ubiquitination | ERYQCSGKDIASQPC CHHCCCCCCHHCCCC | 29.66 | - | |
512 | Phosphorylation | CSGKDIASQPCLVTE CCCCCHHCCCCHHHH | 34.68 | 30631047 | |
518 | Phosphorylation | ASQPCLVTEMLAKFT HCCCCHHHHHHHHHC | 11.61 | 30631047 | |
523 | Ubiquitination | LVTEMLAKFTETEAL HHHHHHHHHCCCHHH | 49.18 | - | |
527 | Phosphorylation | MLAKFTETEALEGKI HHHHHCCCHHHCCCE | 24.41 | - | |
543 | Ubiquitination | VCDQCNSKRRRFSSK EECCCCCCCCCCCCC | 35.61 | - | |
548 | Phosphorylation | NSKRRRFSSKPVVLT CCCCCCCCCCCEECC | 35.32 | - | |
549 | Phosphorylation | SKRRRFSSKPVVLTE CCCCCCCCCCEECCH | 37.96 | - | |
550 | Ubiquitination | KRRRFSSKPVVLTEA CCCCCCCCCEECCHH | 40.40 | - | |
555 | Phosphorylation | SSKPVVLTEAQKQLM CCCCEECCHHHHHHH | 20.05 | - | |
667 | Acetylation | CTMDEVCKAQAYILF CCHHHHHHHHHHHHH | 49.02 | 7380801 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBP44_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
48 | K | ubiquitylation |
| 20402667 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP44_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CETN2_HUMAN | CETN2 | physical | 19615732 | |
RPB7_HUMAN | POLR2G | physical | 19615732 | |
RM23_HUMAN | MRPL23 | physical | 19615732 | |
TCOF_HUMAN | TCOF1 | physical | 19615732 | |
KRR1_HUMAN | KRR1 | physical | 19615732 | |
TBL2_HUMAN | TBL2 | physical | 19615732 | |
RT21_HUMAN | MRPS21 | physical | 19615732 | |
SYSM_HUMAN | SARS2 | physical | 19615732 | |
RM40_HUMAN | MRPL40 | physical | 19615732 | |
RM53_HUMAN | MRPL53 | physical | 19615732 | |
CETN2_HUMAN | CETN2 | physical | 28514442 | |
CETN2_HUMAN | CETN2 | physical | 27880911 | |
TBL1R_HUMAN | TBL1XR1 | physical | 27880911 | |
TBL1X_HUMAN | TBL1X | physical | 27880911 | |
PRS6B_HUMAN | PSMC4 | physical | 27880911 | |
HDAC3_HUMAN | HDAC3 | physical | 27880911 | |
PRS4_HUMAN | PSMC1 | physical | 27880911 | |
PRS7_HUMAN | PSMC2 | physical | 27880911 | |
PRS8_HUMAN | PSMC5 | physical | 27880911 | |
NCOR1_HUMAN | NCOR1 | physical | 27880911 | |
NCOR2_HUMAN | NCOR2 | physical | 27880911 | |
H2B1A_HUMAN | HIST1H2BA | physical | 27880911 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...